Philips Secures FDA Clearance for AI-Powered Verida CT System

Philips has received 510(k) clearance from the U.S. Food and Drug Administration for its Verida system, an AI-enabled spectral computed tomography (CT) platform designed to enhance diagnostic imaging.

Verida uses advanced dual-layer detector technology and AI-based reconstruction to reduce noise and improve image quality. It can process up to 145 images per second, enabling full scans in under 30 seconds and supporting high patient throughput.

The system captures both high- and low-energy data in a single scan, delivering detailed tissue characterization without requiring additional imaging. It also allows clinicians to adjust image de-noising based on clinical needs.

Designed for use across radiology, cardiology, oncology, and interventional procedures, Verida supports a wide range of applications, including whole-body imaging and cancer screening.

The clearance marks a significant step in expanding AI-driven imaging solutions and improving efficiency in clinical workflows.

17-04-2026